Search results
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo News· 2 months agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Ideaya (IDYA) Up on Interim Data from Mid-Stage Eye Cancer Study
Zacks via Yahoo News· 2 years agoIdeaya Biosciences (IDYA) reports positive interim results from its mid-stage study, evaluating...